Show simple item record

dc.creatorMrkić, Ivan
dc.creatorMinić, Rajna
dc.creatorPopović, Dragan
dc.creatorŽivković, Irena
dc.creatorGavrović-Jankulović, Marija
dc.date.accessioned2021-02-18T10:50:17Z
dc.date.available2021-02-18T10:50:17Z
dc.date.issued2018
dc.identifier.issn0024-3205
dc.identifier.urihttp://intor.torlakinstitut.com/handle/123456789/515
dc.description.abstractAim To investigate the immunomodulatory potential of a chimera composed of the receptor-binding domain of hemagglutinin 1 (H1s) from Influenza virus and Der p 2 (D2) allergen for allergen-specific immunotherapy of house-dust mite allergy (HDM). Main methods: H1sD2 chimera and D2 allergen were produced by genetic engineering in E. coli. Recombinant antigens were extracted from inclusion bodies by urea, then refolded and purified by immobilized-metal affinity chromatography (IMAC). Purity was verified by 2D-PAGE and secondary structures were assessed by CD spectroscopy. IgE reactivity of H1sD2 and D2 was tested in western blot with sera from 8 persons with clinical history of HDM allergy. Immunogenicity of H1sD2 and D2 were analyzed in Balb/c mice. Cytokine profile was analyzed by ELISA after stimulation of mouse spleen cells with H1sD2 and D2. Leukocyte population abundance of cells isolated from spleen and lymph node was assessed by flow cytometry. Key findings: Purified recombinant proteins H1sD2 (42 kDa) and D2 (15 kDa) revealed well defined secondary structures, and preserved IgE reactive epitopes. Analysis of supernatants of mouse spleen cells after stimulation with H1sD2 and D2, revealed a qualitatively different cytokine profile from H1sD2 immunized mouse cells (increase in IL10). CD8+ cells were decreased in the lymph node of D2 immunized mice, whereas H1sD2 immunization led to an increase of CD8+ cells in both the lymph node and the spleen. Significance: H1sD2 chimera attenuates Der p 2-inherent Th2 response and directs the immune response toward Th1 and Treg phenotype.en
dc.publisherPergamon-Elsevier Science Ltd, Oxford
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172049/RS//
dc.relation.isversionofhttp://intor.torlakinstitut.com/handle/123456789/646
dc.rightsopenAccess
dc.sourceLife Sciences
dc.subjectAllergyen
dc.subjectHouse dust mitesen
dc.subjectVaccineen
dc.subjectImmunotherapyen
dc.titleNewly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapyen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage165
dc.citation.other213: 158-165
dc.citation.rankM21
dc.citation.spage158
dc.citation.volume213
dc.description.otherPeer-reviewed manuscript: [http://intor.torlakinstitut.com/handle/123456789/646]
dc.identifier.doi10.1016/j.lfs.2018.10.036
dc.identifier.fulltexthttp://intor.torlakinstitut.com/bitstream/id/334/512.pdf
dc.identifier.pmid30352241
dc.identifier.scopus2-s2.0-85055509180
dc.identifier.wos000448413900020
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record